Annual Drug Patent Expirations for RISVAN Risvan is a drug marketed by Labs Farms Rovi Sa and is included in one NDA. The generic ingredient in RISVAN is risperidone. Additional details are available on the risperidone profile page. For more informatio…
Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are thirteen patents protecting this drug. This drug has fifty-nine patent family members in twenty-…
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It is available from seven suppliers. There are two patents protecting this drug and two Paragraph IV challenges. NUVIGIL drug price trends. D…
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Ireland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long time needed to ob…
Which pharmaceutical companies have the most SPCs in Ireland? Read Post »
Annual Drug Patent Expirations for INGREZZA+SPRINKLE Ingrezza Sprinkle is a drug marketed by Neurocrine and is included in one NDA. […]
Source
New patent for Neurocrine drug INGREZZA SPRINKLE Read Post »
Annual Drug Patent Expirations for PLUVICTO Pluvicto is a drug marketed by Novartis and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one […]
Source
Annual Drug Patent Expirations for GAVRETO Gavreto is a drug marketed by Blueprint Medicines and is included in one NDA. […]
Source
This chart shows the patent expirations for tablet dosed drugs over the next decade. The term of drug patents varies. […]
Source
Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are seven patents protecting…
Source